APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Coated Stent System

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug Coated Stent System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

24 December 2025190 pages

Choose your research edition.

Industry ResearchDrug Coated Stent System Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Coated Stent System Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Drug Coated Stent System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Coated Stent System Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Coated Stent System Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Drug Coated Stent System market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drug Coated Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Coated Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Coated Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug Coated Stent System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Coated Stent System include MicroPort Scientific Corporation, Shanghai Bio-heart Biological Technology, Shandong Huaan Biotechnology, SINOMED, Lepu Medical Technology, Blue Sail Medical, Kinhely Bio-Tech, JW Medical Systems and USM Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drug Coated Stent System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Coated Stent System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Coated Stent System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drug Coated Stent System market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Coated Stent System Segment by Company

MicroPort Scientific Corporation

Shanghai Bio-heart Biological Technology

Shandong Huaan Biotechnology

SINOMED

Lepu Medical Technology

Blue Sail Medical

Kinhely Bio-Tech

JW Medical Systems

USM Healthcare

QualiMe

P+F Products + Features GmbH

MicroPort

Medtronic

Concept Medical Inc

Cardionovum

Boston Scientific

Biotronik

Abbott

Drug Coated Stent System Segment by Type

Rapamycin Coated Stent

Ivimox Coated Bracket

Paclitaxel Coated Stent

Zothamos Coated Bracket

Drug Coated Stent System Segment by Application

Hospital

Clinic

Others

Drug Coated Stent System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Coated Stent System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Coated Stent System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Coated Stent System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drug Coated Stent System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug Coated Stent System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drug Coated Stent System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drug Coated Stent System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drug Coated Stent System Industry Trends Table 2. Drug Coated Stent System Industry Drivers Table 3. Drug Coated Stent System Industry Opportunities and Challenges Table 4. Drug Coated Stent System Industry Restraints Table 5. Global Drug Coated Stent System Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drug Coated Stent System Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drug Coated Stent System Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Drug Coated Stent System Sales Market Share by Manufacturers Table 9. Global Drug Coated Stent System Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Drug Coated Stent System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drug Coated Stent System Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drug Coated Stent System Manufacturers, Product Type & Application Table 13. Global Drug Coated Stent System Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drug Coated Stent System by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Rapamycin Coated Stent Table 17. Major Manufacturers of Ivimox Coated Bracket Table 18. Major Manufacturers of Paclitaxel Coated Stent Table 19. Major Manufacturers of Zothamos Coated Bracket Table 20. Global Drug Coated Stent System Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Drug Coated Stent System Sales by Type (2021-2026) & (K Units) Table 22. Global Drug Coated Stent System Sales by Type (2027-2032) & (K Units) Table 23. Global Drug Coated Stent System Sales Market Share by Type (2021-2026) Table 24. Global Drug Coated Stent System Sales Market Share by Type (2027-2032) Table 25. Global Drug Coated Stent System Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Drug Coated Stent System Revenue by Type (2021-2026) & (K Units) Table 27. Global Drug Coated Stent System Revenue by Type (2027-2032) & (K Units) Table 28. Global Drug Coated Stent System Revenue Market Share by Type (2021-2026) Table 29. Global Drug Coated Stent System Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Major Manufacturers of Others Table 33. Global Drug Coated Stent System Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Drug Coated Stent System Sales by Application (2021-2026) & (K Units) Table 35. Global Drug Coated Stent System Sales by Application (2027-2032) & (K Units) Table 36. Global Drug Coated Stent System Sales Market Share by Application (2021-2026) Table 37. Global Drug Coated Stent System Sales Market Share by Application (2027-2032) Table 38. Global Drug Coated Stent System Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Drug Coated Stent System Revenue by Application (2021-2026) & (K Units) Table 40. Global Drug Coated Stent System Revenue by Application (2027-2032) & (K Units) Table 41. Global Drug Coated Stent System Revenue Market Share by Application (2021-2026) Table 42. Global Drug Coated Stent System Revenue Market Share by Application (2027-2032) Table 43. Global Drug Coated Stent System Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Drug Coated Stent System Sales by Region (2021-2026) & (K Units) Table 45. Global Drug Coated Stent System Sales Market Share by Region (2021-2026) Table 46. Global Drug Coated Stent System Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Drug Coated Stent System Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Drug Coated Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Drug Coated Stent System Sales by Country (2021-2026) & (K Units) Table 50. North America Drug Coated Stent System Sales by Country (2027-2032) & (K Units) Table 51. Europe Drug Coated Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Drug Coated Stent System Sales by Country (2021-2026) & (K Units) Table 53. Europe Drug Coated Stent System Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Drug Coated Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Drug Coated Stent System Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Drug Coated Stent System Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Drug Coated Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Drug Coated Stent System Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Drug Coated Stent System Sales by Country (2027-2032) & (K Units) Table 60. Global Drug Coated Stent System Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Drug Coated Stent System Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Drug Coated Stent System Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Drug Coated Stent System Revenue Market Share by Region (2021-2026) Table 64. Global Drug Coated Stent System Revenue Market Share by Region (2027-2032) Table 65. MicroPort Scientific Corporation Company Information Table 66. MicroPort Scientific Corporation Business Overview Table 67. MicroPort Scientific Corporation Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. MicroPort Scientific Corporation Drug Coated Stent System Product Portfolio Table 69. MicroPort Scientific Corporation Recent Development Table 70. Shanghai Bio-heart Biological Technology Company Information Table 71. Shanghai Bio-heart Biological Technology Business Overview Table 72. Shanghai Bio-heart Biological Technology Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Shanghai Bio-heart Biological Technology Drug Coated Stent System Product Portfolio Table 74. Shanghai Bio-heart Biological Technology Recent Development Table 75. Shandong Huaan Biotechnology Company Information Table 76. Shandong Huaan Biotechnology Business Overview Table 77. Shandong Huaan Biotechnology Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Shandong Huaan Biotechnology Drug Coated Stent System Product Portfolio Table 79. Shandong Huaan Biotechnology Recent Development Table 80. SINOMED Company Information Table 81. SINOMED Business Overview Table 82. SINOMED Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. SINOMED Drug Coated Stent System Product Portfolio Table 84. SINOMED Recent Development Table 85. Lepu Medical Technology Company Information Table 86. Lepu Medical Technology Business Overview Table 87. Lepu Medical Technology Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Lepu Medical Technology Drug Coated Stent System Product Portfolio Table 89. Lepu Medical Technology Recent Development Table 90. Blue Sail Medical Company Information Table 91. Blue Sail Medical Business Overview Table 92. Blue Sail Medical Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Blue Sail Medical Drug Coated Stent System Product Portfolio Table 94. Blue Sail Medical Recent Development Table 95. Kinhely Bio-Tech Company Information Table 96. Kinhely Bio-Tech Business Overview Table 97. Kinhely Bio-Tech Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Kinhely Bio-Tech Drug Coated Stent System Product Portfolio Table 99. Kinhely Bio-Tech Recent Development Table 100. JW Medical Systems Company Information Table 101. JW Medical Systems Business Overview Table 102. JW Medical Systems Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. JW Medical Systems Drug Coated Stent System Product Portfolio Table 104. JW Medical Systems Recent Development Table 105. USM Healthcare Company Information Table 106. USM Healthcare Business Overview Table 107. USM Healthcare Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. USM Healthcare Drug Coated Stent System Product Portfolio Table 109. USM Healthcare Recent Development Table 110. QualiMe Company Information Table 111. QualiMe Business Overview Table 112. QualiMe Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. QualiMe Drug Coated Stent System Product Portfolio Table 114. QualiMe Recent Development Table 115. P+F Products + Features GmbH Company Information Table 116. P+F Products + Features GmbH Business Overview Table 117. P+F Products + Features GmbH Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. P+F Products + Features GmbH Drug Coated Stent System Product Portfolio Table 119. P+F Products + Features GmbH Recent Development Table 120. MicroPort Company Information Table 121. MicroPort Business Overview Table 122. MicroPort Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. MicroPort Drug Coated Stent System Product Portfolio Table 124. MicroPort Recent Development Table 125. Medtronic Company Information Table 126. Medtronic Business Overview Table 127. Medtronic Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Medtronic Drug Coated Stent System Product Portfolio Table 129. Medtronic Recent Development Table 130. Concept Medical Inc Company Information Table 131. Concept Medical Inc Business Overview Table 132. Concept Medical Inc Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Concept Medical Inc Drug Coated Stent System Product Portfolio Table 134. Concept Medical Inc Recent Development Table 135. Cardionovum Company Information Table 136. Cardionovum Business Overview Table 137. Cardionovum Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Cardionovum Drug Coated Stent System Product Portfolio Table 139. Cardionovum Recent Development Table 140. Boston Scientific Company Information Table 141. Boston Scientific Business Overview Table 142. Boston Scientific Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Boston Scientific Drug Coated Stent System Product Portfolio Table 144. Boston Scientific Recent Development Table 145. Biotronik Company Information Table 146. Biotronik Business Overview Table 147. Biotronik Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Biotronik Drug Coated Stent System Product Portfolio Table 149. Biotronik Recent Development Table 150. Abbott Company Information Table 151. Abbott Business Overview Table 152. Abbott Drug Coated Stent System Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Abbott Drug Coated Stent System Product Portfolio Table 154. Abbott Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Drug Coated Stent System Distributors List Table 158. Drug Coated Stent System Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Drug Coated Stent System Product Image Figure 2. Global Drug Coated Stent System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Coated Stent System Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Coated Stent System Sales (2021-2032) & (K Units) Figure 5. Global Drug Coated Stent System Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drug Coated Stent System Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Rapamycin Coated Stent Image Figure 9. Ivimox Coated Bracket Image Figure 10. Paclitaxel Coated Stent Image Figure 11. Zothamos Coated Bracket Image Figure 12. Global Drug Coated Stent System Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Drug Coated Stent System Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Drug Coated Stent System Sales Market Share by Type (2021-2032) Figure 15. Global Drug Coated Stent System Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Drug Coated Stent System Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Drug Coated Stent System Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Drug Coated Stent System Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Drug Coated Stent System Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Drug Coated Stent System Sales Market Share by Application (2021-2032) Figure 24. Global Drug Coated Stent System Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Drug Coated Stent System Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Drug Coated Stent System Revenue Market Share by Application (2021-2032) Figure 27. North America Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Drug Coated Stent System Sales Market Share by Country (2021-2032) Figure 29. U.S. Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Drug Coated Stent System Sales Market Share by Country (2021-2032) Figure 34. Germany Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Drug Coated Stent System Sales Market Share by Country (2021-2032) Figure 41. China Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Drug Coated Stent System Sales Market Share by Country (2021-2032) Figure 49. Brazil Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Drug Coated Stent System Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Drug Coated Stent System Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Drug Coated Stent System Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Drug Coated Stent System Revenue (2021-2032) & (US$ Million) Figure 60. North America Drug Coated Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Drug Coated Stent System Revenue (2021-2032) & (US$ Million) Figure 62. Europe Drug Coated Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Drug Coated Stent System Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Drug Coated Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Drug Coated Stent System Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Drug Coated Stent System Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Drug Coated Stent System Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Drug Coated Stent System Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Rapamycin Coated Stent
  • Ivimox Coated Bracket
  • Paclitaxel Coated Stent
  • Zothamos Coated Bracket
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • MicroPort Scientific Corporation
  • Shanghai Bio-heart Biological Technology
  • Shandong Huaan Biotechnology
  • SINOMED
  • Lepu Medical Technology
  • Blue Sail Medical
  • Kinhely Bio-Tech
  • JW Medical Systems
  • USM Healthcare
  • QualiMe
  • P+F Products + Features GmbH
  • MicroPort
  • Medtronic
  • Concept Medical Inc
  • Cardionovum
  • Boston Scientific
  • Biotronik
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Coated Stent System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Coated Stent System Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drug Coated Stent System Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drug Coated Stent System Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drug Coated Stent System Market Dynamics
  1. 2.1 Drug Coated Stent System Industry Trends
  2. 2.2 Drug Coated Stent System Industry Drivers
  3. 2.3 Drug Coated Stent System Industry Opportunities and Challenges
  4. 2.4 Drug Coated Stent System Industry Restraints
3 Drug Coated Stent System Market by Manufacturers
  1. 3.1 Global Drug Coated Stent System Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drug Coated Stent System Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drug Coated Stent System Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drug Coated Stent System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug Coated Stent System Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drug Coated Stent System Manufacturers, Product Type & Application
  7. 3.7 Global Drug Coated Stent System Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug Coated Stent System Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug Coated Stent System Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug Coated Stent System Tier 1, Tier 2, and Tier 3
4 Drug Coated Stent System Market by Type
  1. 4.1 Drug Coated Stent System Type Introduction
  2. 4.1.1 Rapamycin Coated Stent
  3. 4.1.2 Ivimox Coated Bracket
  4. 4.1.3 Paclitaxel Coated Stent
  5. 4.1.4 Zothamos Coated Bracket
  6. 4.2 Global Drug Coated Stent System Sales by Type
  7. 4.2.1 Global Drug Coated Stent System Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Drug Coated Stent System Sales by Type (2021-2032)
  9. 4.2.3 Global Drug Coated Stent System Sales Market Share by Type (2021-2032)
  10. 4.3 Global Drug Coated Stent System Revenue by Type
  11. 4.3.1 Global Drug Coated Stent System Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Drug Coated Stent System Revenue by Type (2021-2032)
  13. 4.3.3 Global Drug Coated Stent System Revenue Market Share by Type (2021-2032)
5 Drug Coated Stent System Market by Application
  1. 5.1 Drug Coated Stent System Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Drug Coated Stent System Sales by Application
  6. 5.2.1 Global Drug Coated Stent System Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug Coated Stent System Sales by Application (2021-2032)
  8. 5.2.3 Global Drug Coated Stent System Sales Market Share by Application (2021-2032)
  9. 5.3 Global Drug Coated Stent System Revenue by Application
  10. 5.3.1 Global Drug Coated Stent System Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Drug Coated Stent System Revenue by Application (2021-2032)
  12. 5.3.3 Global Drug Coated Stent System Revenue Market Share by Application (2021-2032)
6 Global Drug Coated Stent System Sales by Region
  1. 6.1 Global Drug Coated Stent System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Coated Stent System Sales by Region (2021-2032)
  3. 6.2.1 Global Drug Coated Stent System Sales by Region (2021-2026)
  4. 6.2.2 Global Drug Coated Stent System Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Coated Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drug Coated Stent System Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drug Coated Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drug Coated Stent System Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drug Coated Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drug Coated Stent System Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drug Coated Stent System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drug Coated Stent System Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drug Coated Stent System Revenue by Region
  1. 7.1 Global Drug Coated Stent System Revenue by Region
  2. 7.1.1 Global Drug Coated Stent System Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drug Coated Stent System Revenue by Region (2021-2026)
  4. 7.1.3 Global Drug Coated Stent System Revenue by Region (2027-2032)
  5. 7.1.4 Global Drug Coated Stent System Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drug Coated Stent System Revenue (2021-2032)
  8. 7.2.2 North America Drug Coated Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drug Coated Stent System Revenue (2021-2032)
  11. 7.3.2 Europe Drug Coated Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drug Coated Stent System Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drug Coated Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drug Coated Stent System Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drug Coated Stent System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 MicroPort Scientific Corporation
  2. 8.1.1 MicroPort Scientific Corporation Company Information
  3. 8.1.2 MicroPort Scientific Corporation Business Overview
  4. 8.1.3 MicroPort Scientific Corporation Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MicroPort Scientific Corporation Drug Coated Stent System Product Portfolio
  6. 8.1.5 MicroPort Scientific Corporation Recent Developments
  7. 8.2 Shanghai Bio-heart Biological Technology
  8. 8.2.1 Shanghai Bio-heart Biological Technology Company Information
  9. 8.2.2 Shanghai Bio-heart Biological Technology Business Overview
  10. 8.2.3 Shanghai Bio-heart Biological Technology Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Bio-heart Biological Technology Drug Coated Stent System Product Portfolio
  12. 8.2.5 Shanghai Bio-heart Biological Technology Recent Developments
  13. 8.3 Shandong Huaan Biotechnology
  14. 8.3.1 Shandong Huaan Biotechnology Company Information
  15. 8.3.2 Shandong Huaan Biotechnology Business Overview
  16. 8.3.3 Shandong Huaan Biotechnology Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Huaan Biotechnology Drug Coated Stent System Product Portfolio
  18. 8.3.5 Shandong Huaan Biotechnology Recent Developments
  19. 8.4 SINOMED
  20. 8.4.1 SINOMED Company Information
  21. 8.4.2 SINOMED Business Overview
  22. 8.4.3 SINOMED Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SINOMED Drug Coated Stent System Product Portfolio
  24. 8.4.5 SINOMED Recent Developments
  25. 8.5 Lepu Medical Technology
  26. 8.5.1 Lepu Medical Technology Company Information
  27. 8.5.2 Lepu Medical Technology Business Overview
  28. 8.5.3 Lepu Medical Technology Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lepu Medical Technology Drug Coated Stent System Product Portfolio
  30. 8.5.5 Lepu Medical Technology Recent Developments
  31. 8.6 Blue Sail Medical
  32. 8.6.1 Blue Sail Medical Company Information
  33. 8.6.2 Blue Sail Medical Business Overview
  34. 8.6.3 Blue Sail Medical Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Blue Sail Medical Drug Coated Stent System Product Portfolio
  36. 8.6.5 Blue Sail Medical Recent Developments
  37. 8.7 Kinhely Bio-Tech
  38. 8.7.1 Kinhely Bio-Tech Company Information
  39. 8.7.2 Kinhely Bio-Tech Business Overview
  40. 8.7.3 Kinhely Bio-Tech Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kinhely Bio-Tech Drug Coated Stent System Product Portfolio
  42. 8.7.5 Kinhely Bio-Tech Recent Developments
  43. 8.8 JW Medical Systems
  44. 8.8.1 JW Medical Systems Company Information
  45. 8.8.2 JW Medical Systems Business Overview
  46. 8.8.3 JW Medical Systems Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 JW Medical Systems Drug Coated Stent System Product Portfolio
  48. 8.8.5 JW Medical Systems Recent Developments
  49. 8.9 USM Healthcare
  50. 8.9.1 USM Healthcare Company Information
  51. 8.9.2 USM Healthcare Business Overview
  52. 8.9.3 USM Healthcare Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 USM Healthcare Drug Coated Stent System Product Portfolio
  54. 8.9.5 USM Healthcare Recent Developments
  55. 8.10 QualiMe
  56. 8.10.1 QualiMe Company Information
  57. 8.10.2 QualiMe Business Overview
  58. 8.10.3 QualiMe Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 QualiMe Drug Coated Stent System Product Portfolio
  60. 8.10.5 QualiMe Recent Developments
  61. 8.11 P+F Products + Features GmbH
  62. 8.11.1 P+F Products + Features GmbH Company Information
  63. 8.11.2 P+F Products + Features GmbH Business Overview
  64. 8.11.3 P+F Products + Features GmbH Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 P+F Products + Features GmbH Drug Coated Stent System Product Portfolio
  66. 8.11.5 P+F Products + Features GmbH Recent Developments
  67. 8.12 MicroPort
  68. 8.12.1 MicroPort Company Information
  69. 8.12.2 MicroPort Business Overview
  70. 8.12.3 MicroPort Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 MicroPort Drug Coated Stent System Product Portfolio
  72. 8.12.5 MicroPort Recent Developments
  73. 8.13 Medtronic
  74. 8.13.1 Medtronic Company Information
  75. 8.13.2 Medtronic Business Overview
  76. 8.13.3 Medtronic Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Medtronic Drug Coated Stent System Product Portfolio
  78. 8.13.5 Medtronic Recent Developments
  79. 8.14 Concept Medical Inc
  80. 8.14.1 Concept Medical Inc Company Information
  81. 8.14.2 Concept Medical Inc Business Overview
  82. 8.14.3 Concept Medical Inc Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Concept Medical Inc Drug Coated Stent System Product Portfolio
  84. 8.14.5 Concept Medical Inc Recent Developments
  85. 8.15 Cardionovum
  86. 8.15.1 Cardionovum Company Information
  87. 8.15.2 Cardionovum Business Overview
  88. 8.15.3 Cardionovum Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cardionovum Drug Coated Stent System Product Portfolio
  90. 8.15.5 Cardionovum Recent Developments
  91. 8.16 Boston Scientific
  92. 8.16.1 Boston Scientific Company Information
  93. 8.16.2 Boston Scientific Business Overview
  94. 8.16.3 Boston Scientific Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Boston Scientific Drug Coated Stent System Product Portfolio
  96. 8.16.5 Boston Scientific Recent Developments
  97. 8.17 Biotronik
  98. 8.17.1 Biotronik Company Information
  99. 8.17.2 Biotronik Business Overview
  100. 8.17.3 Biotronik Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Biotronik Drug Coated Stent System Product Portfolio
  102. 8.17.5 Biotronik Recent Developments
  103. 8.18 Abbott
  104. 8.18.1 Abbott Company Information
  105. 8.18.2 Abbott Business Overview
  106. 8.18.3 Abbott Drug Coated Stent System Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Abbott Drug Coated Stent System Product Portfolio
  108. 8.18.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drug Coated Stent System Value Chain Analysis
  2. 9.1.1 Drug Coated Stent System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drug Coated Stent System Production Mode & Process
  6. 9.2 Drug Coated Stent System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drug Coated Stent System Distributors
  9. 9.2.3 Drug Coated Stent System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst